Demonstration of the increased expression of activation and costimulatory molecules (e.g., CD38, CD69, CD40, HLA-DR CD71, CD62L, and CD39) led to the hypothesis that CLL B-cells are derived from activated and Ag-experienced B lymphocytes (158). Here, CD38 is linked to B-cell chronic lymphocytic leukemia.